HCC Healthcare to merge with RF Acquisition III in $500M SPAC deal, Nasdaq listing planned
Jul 9, 2026, 5:29 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Directly driven by a formal merger with a clear closing timeline; near-term upside if approvals progress and redemptions are manageable; downside if redemptions spike or closing conditions falter, a common risk in SPAC deals.
AI summary
What happened, with direct paths to the underlying reporting
RF Acquisition III signed a business combination with HCC Healthcare, valuing the target at about US$500 million. The deal aims to list on Nasdaq upon close, currently targeted for Q4 2026 and contingent on shareholder approvals and Form F-4 effectiveness. The combined platform will scale across Taiwan and Japan with AI-enabled care and broader long-term care services, presenting a regional growth thesis but with typical SPAC-close risks.
RF Acquisition III to merge with HCC Healthcare; US$500M equity value.
Transaction targeted to close in Q4 2026, subject to approvals and Form F-4.
Pro forma network: 120+ long-term care facilities and 9,000+ beds.
HCC emphasizes AI-enabled care, Japan expansion, and a Nasdaq listing post-close.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event